Page last updated: 2024-08-23

mifepristone and ru 43044

mifepristone has been researched along with ru 43044 in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's3 (60.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hansen, PJ; Monterroso, VH1
De Bosscher, K; Francesconi, E; Haegeman, G; Resche-Rigon, M; Vanden Berghe, W1
Archer, TK; Fryer, CJ; Garabedian, MJ; Kinyamu, HK; Rogatsky, I1
Benhamou, B; Gofflo, D; Guillot, B; Moras, D; Ossart, C; Philibert, D; Robin-Jagerschmidt, C; Vergezac, A; Wurtz, JM1
Belikov, S; Gelius, B; Wrange , O1

Other Studies

5 other study(ies) available for mifepristone and ru 43044

ArticleYear
Regulation of bovine and ovine lymphocyte proliferation by progesterone: modulation by steroid receptor antagonists and physiological status.
    Acta endocrinologica, 1993, Volume: 129, Issue:6

    Topics: Animals; Cattle; Dose-Response Relationship, Drug; Drug Synergism; Female; Glucocorticoids; Hydroxycorticosteroids; Lactation; Lymphocyte Activation; Mifepristone; Osmolar Concentration; Progesterone; Receptors, Steroid; Sheep

1993
Dissociated glucocorticoids with anti-inflammatory potential repress interleukin-6 gene expression by a nuclear factor-kappaB-dependent mechanism.
    Molecular pharmacology, 1999, Volume: 56, Issue:4

    Topics: Animals; Anti-Inflammatory Agents; DNA; DNA-Binding Proteins; Gene Expression Regulation; Genes, Reporter; Glucocorticoids; HeLa Cells; Hormone Antagonists; Humans; Hydroxycorticosteroids; I-kappa B Proteins; Interleukin-6; Mice; Mifepristone; NF-kappa B; NF-KappaB Inhibitor alpha; Promoter Regions, Genetic; Trans-Activators; Transcription Factor AP-1; Transcription, Genetic; Transcriptional Activation; Tumor Cells, Cultured

1999
Selective activation of the glucocorticoid receptor by steroid antagonists in human breast cancer and osteosarcoma cells.
    The Journal of biological chemistry, 2000, Jun-09, Volume: 275, Issue:23

    Topics: Animals; Breast Neoplasms; Dexamethasone; Female; Gene Expression Regulation, Neoplastic; Glucocorticoids; Hormone Antagonists; Humans; Hydroxycorticosteroids; Mammary Tumor Virus, Mouse; Mice; Mifepristone; Osteosarcoma; Promoter Regions, Genetic; Receptors, Glucocorticoid; Transcription, Genetic; Tumor Cells, Cultured

2000
Residues in the ligand binding domain that confer progestin or glucocorticoid specificity and modulate the receptor transactivation capacity.
    Molecular endocrinology (Baltimore, Md.), 2000, Volume: 14, Issue:7

    Topics: Amino Acid Sequence; Animals; Base Sequence; Binding Sites; Furylfuramide; Glucocorticoids; Hormone Antagonists; Humans; Hydroxycorticosteroids; Mifepristone; Models, Molecular; Molecular Sequence Data; Progestins; Promegestone; Protein Conformation; Receptors, Glucocorticoid; Receptors, Progesterone; Recombinant Proteins; Sequence Homology, Amino Acid; Substrate Specificity; Transcriptional Activation

2000
Hormone-induced nucleosome positioning in the MMTV promoter is reversible.
    The EMBO journal, 2001, Jun-01, Volume: 20, Issue:11

    Topics: Animals; Chromatin; Female; Glucocorticoids; Hormone Antagonists; Hydroxycorticosteroids; Mammary Tumor Virus, Mouse; Mice; Mifepristone; Nucleosomes; Oocytes; Promoter Regions, Genetic; Protein Biosynthesis; Rats; Receptors, Glucocorticoid; Recombinant Proteins; Transcription, Genetic; Xenopus laevis

2001